Company Filing History:
Years Active: 1997-1999
Title: Christine Lange Cannova: Innovator in Antiprotozoal Research
Introduction
Christine Lange Cannova is a notable inventor based in Toms River, NJ (US). She has made significant contributions to the field of medicine, particularly in the development of novel compounds for the treatment of protozoal diseases. With a total of 2 patents, her work is paving the way for advancements in healthcare.
Latest Patents
Christine's latest patents focus on antiprotozoal cyclic tetrapeptides. The present invention provides novel cyclic tetrapeptides that are useful in the treatment or prevention of protozoal diseases. In particular, these novel compounds are active against the causative pathogens in malaria, toxoplasmosis, and coccidiosis. This innovative approach has the potential to significantly impact the treatment landscape for these diseases.
Career Highlights
Christine Lange Cannova is currently associated with Merck & Company, Inc., where she continues her research and development efforts. Her work at Merck has allowed her to collaborate with leading experts in the field and contribute to groundbreaking advancements in medicine.
Collaborations
Some of her notable coworkers include Michael A Goetz and Anne W Dombrowski. Their collaborative efforts have further enhanced the research and development of antiprotozoal therapies.
Conclusion
Christine Lange Cannova's contributions to the field of antiprotozoal research exemplify her dedication to innovation and improving healthcare outcomes. Her work is a testament to the impact that inventors can have on society through their inventions.